-
21
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
22
Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
Published 2025-01-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
23
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
24
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
25
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
26
Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrosp...
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
27
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter P...
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
28
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
29
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
30
Interventional factors influencing natural killer cell immunity in colorectal cancer: a systematic review
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
31
Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or second...
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
32
Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
33
NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
34
Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
35
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting syste...
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
36
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective lon...
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
37
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
38
Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
39
Ly6E on tumor cells impairs anti-tumor T-cell responses: a novel mechanism of tumor-induced immune exclusion
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
40
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article